ProSciento Overview: Clinical R&D Services for Metabolic Diseases

About

ProSciento is a global clinical research organization, exclusively focused on drug and device development programs for diabetes, NASH, obesity and related metabolic diseases. Building on two decades of experience and more than 425 completed metabolic clinical trials, ProSciento provides customized clinical research services for multinational clinical trial programs. Our scalable R&D service model incorporates therapeutic expertise, advanced methodologies, patient access strategies, and global operational excellence to provide our clients an unique advantage in today’s rapidly evolving landscape of metabolic drug and device development.

ProSciento Overview: Clinical R&D Services for Metabolic Diseases thumbnail

Recommended Materials

ProSciento Overview: Clinical R&D Services for Metabolic Diseases thumbnail

Fact Sheets

Specialized Expertise to Drive Advances in Diabetes Drug and Device Development

ProSciento Overview: Clinical R&D Services for Metabolic Diseases thumbnail

Fact Sheets

Clinical Research Strategies to Drive Advances in Obesity Drug Development

Related Solutions

Metabolic Continuum thumbnail

Our Metabolic Focus

Overview thumbnail

About Us